Subacute echocardiographic effects of ACE inhibitors in the dogs with severe mitral regurgitation

• Autorzy: Bakirel U , Gunes S. , Meral Y. , Bakirel T.
• Języki publikacji: EN

Abstrakty

EN

The effects of the angiotensin converting enzyme inhibitors benazepril (B), enalapril (E), and ramipril (R) on the function, geometry, and dimensions of the left ventricle (LV) in the dogs with naturally acquired severe mitral regurgitation (MR) were evaluated by echocardiography. Thirty-two dogs, aged 8-16 years and weighing 10-12 kg, with fractional shortening (FS) >50% were included into the study. Benazepril (0.5mg/kg/d), enalapril (0.5mg/kg/d), and ramipril (0.5mg/kg/d) were administered orally to B, E, and R groups, respectively. Furosemide (2mg/kg/d) was administered orally for conventional heart failure therapy. Physical, radiographic, electrocardiographic, and echocardiographic examinations were performed before treatment and on day 7 after the treatment. A decrease in the left ventricle end diastolic diameter (LVEDd) in groups E and R and in end diastolic volume (EDV) in group E was considerable during the subacute period (P<0.05). The stroke volume (SV) significantly decreased in groups E and R (P<0.01), whereas group B dogs had a mild decrease (P<0.05). FS and ejection fraction (EF) that were higher before treatment decreased significantly in all groups after the treatment (P<0.001). Differences in SV, FS, and EF were not statistically significant between groups. It was detected that LV was remodelled as a result of the effects of enalapril and ramipril on LVEDd and also EDV was decreased by enalapril. Furthermore, it was observed that these ACE inhibitors were effective on geometry, dimensions, and functions on LV of the dogs with severe MR, and enalapril was found to be the most effective agent, followed by ramipril and benazepril.

Słowa kluczowe

EN

enalapril; ramipril; veterinary medicine; benazepril; mitral regurgitation; angiotensin converting enzyme; echocardiographic effect; animal disease; inhibitor; dog

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 3
• Opis fizyczny: p.471-475,fig.,ref.

Twórcy

autor

Bakirel U

• Istanbul University, 34851 Avcilar-Istanbul, Turkey

autor

Gunes S.

autor

Meral Y.

autor

Bakirel T.

Bibliografia

• 1. Amberger C., Glardon O., Lombard C.W.: Validité des examens complementaires dans 1'évaluation de l'insuffisance cardiaque par endocardiose mitrale: étude à partir de 106 case. Pract Med Chirurg Anim Comp 1995, 30, 659-670.
• 2. Bonagura J.D.: M-mode echocardiography: basic principles. Vet Clin North Am Small Anim Pract 1983, 13, 299-319.
• 3. Bonagura J.D., Herring D.S.: Echocardiography: acquired heart disease. Vet Clin North Am Small Anim Pract 1985, 15, 1209-1224.
• 4. Borgarelli M., Zini E., D'Agnolo G., Tarducci A., Santilli R.A., Chiavegato. D., Prunotto M., Haggsstörm J. Comparison of primary mitral valve disease in German shepherd dogs and in small breeds. J Vet Cardiol 2004, 6, 27-34.
• 5. Buchanan J.W.: Chronic valvular disease (endocardiosis) in dogs. Adv Vet Sci 1977, 21, 57-106.
• 6. Buchanan J.W.: Causes and prevalence of cardiovascular disease. In: Current Veterinary Therapy XI, edited by R. Kirk, J. Bonagura, Philadelphia, WB Saunders Co., 1992, pp. 647-655.
• 7. COVE Study Group: Controlled clinical evaluation of enalapril in dogs with heart failure: results of the cooperative veterinary enalapril study group. J Vet Intern Med 1995, 9, 234-242.
• 8. Fann J.I., Ingels N.B.I., Miller D.C.: Pathophysiology of mitral valve disease. In: Cardiac Surgery in the Adult, edited by L.H. Cohn, L.H Edmunds, New York, McGraw-Hill, 2003, pp. 901-931.
• 9. Haggström I., Hansson K., Karlberg B.: Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels. Am J Vet Res 1994, 55, 698-703.
• 10. IMPROVE Study Group: Acute and short-term hemodynamic, echcardiographic, and clinical effects of enalapril meleate in dogs with naturally acquired heart failure: results of invasive mulicenter prospective veterinary evaluation of enalapril study. J Vet Intern Med 1995, 9, 243-252.
• 11. Keren G., Katz S., Storm J., Sonnenblick E.H., Lejemtel T.: Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 1989, 80, 306-313.
• 12. Kihara Y., Sasayama S., Miyazaki S.: Role of left atrium in adaptation of the heart to chronic mitral regurgitation in conscious dogs. Circ Res 1988, 62, 543-553.
• 13. Kittleson M.D., Kienle R.: Small Animal Cardiovascular Medicine. Louis, Mosby Inc, 1998, pp. 297-318.
• 14. Komamura K., Shannon R.P., Ihara T.: Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol 1993, 265, 1119-1131.
• 15. Mori Y., Nakazava M., Tomimatsu H., Momma K.: Long-term effect angiotensin converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study. I Am Coll Cardiol 2000, 36, 270-275.
• 16. Muzzi R.A.L., Araujo R.B., Muzzi L.A.L., Pena J.L.B., Silva E.F.: Regurgitation jet area by Doppler color flow mapping: quantitative assessment of mitral regurgitation severity in dogs. J Vet Cardiol 2003, 5, 33-38.
• 17. Nemoto S., Hamawaki M., De Freitas G.: Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 2002, 40, 149-154.
• 18. Parfitt K., Parsons A., Sweetman S.C.: Martindale: The extra pharmacopoeia. London, Pharmaceutical Press, 1993, pp. 339-392.
• 19. Perdersen H.D., Haggström I.: Mitral valve prolaps in the dog: a model mitral valve prolaps in man. Cardiol Res 2000, 47, 234-243.
• 20. Perry G.I., Chang W.C., Hankes G.H., Dillon S.R., Rynders P., Mukherjee R., Spinale F.G., Dell'Italia L.J.: Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dogs. I Am Coll Cardiol 2002, 39, 1374-1379.
• 21. Sabbah H.N., Shimoyama H., Kono T.: Effects of long- term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilatation in dogs with reduced ejection fraction. Circulation 1994, 9, 2852-2859.
• 22. Sahn D.J., DeMaria A., Kisslo J., Weyman A.: The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantization in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58, 1072-1083.
• 23. Shimoyoma H., Sabbah H.N., Rosman H., Kono T., Alam M., Goldstein S.: Effects of long-term therapy with enalapril on severity of functional mitral regurgitation in dogs with moderate heart failure. Am Coll Cardiology 1995, 25, 768-772.
• 24. Sisson D., Kvart C.P.: Acquired valvular heart disease in dogs and cats. In: Textbook of Canine and Feline Cardiology, edited by P.R. Fox, D. Sisson, N.S. Moise, Philadelphia, WB Saunders Co, 1999, pp. 536-555.
• 25. Smith P.I., French A.T., Van Israel N., Smith S.G.W., Switf S.T., Lee A.J., Corcoran B.M., Dukes-McEvan J.: Efficacy and safety of pimobendan in canine heart failure caused by myxomatous mitral valve disease. J Small Anim Pract 2005, 46, 121-130.
• 26. Thomas W.P.: Two dimensional real-time echocardiography in the dog: technique and validation. Vet Radiol 1984, 2, 50-64.
• 27. Wisenbaugh T., Essop R., Rotlisberger C., Sareli P.: Effects of a single oral dose of on left ventricular performance in severe mitral regurgitation. Am I Cardiol 1992, 69, 348-353.